Language Translation
  Close Menu


What does INSPECT Stand for?

Collection &
Tracking Program

INSPECT is Indiana's prescription drug monitoring program (PDMP). INSPECT collects and tracks controlled substance prescriptions that are dispensed to Indiana residents. This data is then made available to medical practitioners and law enforcement to access under certain conditions. Indiana law requires physicians to query Indiana’s prescription drug monitoring program (INSPECT) at the outset of an opioid treatment plan and at least annually thereafter. INSPECT will allow physicians to see if a patient is obtaining controlled substances from multiple practitioners and/or multiple pharmacies, which is known as "doctor-shopping."" A healthcare practitioner accessing INSPECT and obtaining Rx History Reports will be informed of the complete controlled substance history of their patients. Rx History Reports are usually immediately available moments after the request is submitted. The report assists practitioners with patient evaluation and in determining the best treatment and care for a patient. A report may give a practitioner confidence in prescribing a controlled substance to a patient or may deter the practitioner from writing a prescription for a controlled substance altogether.

Why do medical professionals need to know about INSPECT?

It is no secret that there are rising prescription drug challenges for both patients and physicians. These range from more complications in administration, to access, and unfortunately even to that of abuse and dealing. One of the leading tools against these issues is that of Indiana’s nationally recognized INSPECT Prescription Drug Monitoring Program. This program is administered by the Indiana Professional Licensing Agency (IPLA). The Indiana Attorney General's Prescription Drug Abuse Task Force also participates in an advisory council capacity for this program. We believe that ALL citizens of Indiana have a stake in its success.

INSPECT allows registered physicians and medical professionals to confirm patient history and better equips them to understand each patient’s patterns of behavior and filling of prescriptions. This tool is linked to some of our surrounding states to ensure that a more comprehensive picture of the patient history is available. Ohio, Virginia, Arizona, Connecticut, Kansas, North Dakota, Illinois, Kentucky, and Michigan are currently each connected to the database. Each day IPLA works to further integrate data with other states and health care systems. Over 12 million records are collected annually. With painkillers and other abused drugs ranking highest on the prescribed drug reports, we need more than instinct to ensure patients are not becoming statistics.

The 2013 IPLA INSPECT Knowledge and Use Survey indicates that in the last 12 months 35.7% of prescribers have changed their prescribing practices related to controlled substances and of those prescribers 56.6% of prescribers changed their prescribing practices due to INSPECT providing greater access to patient prescription drug history.

Ease of use is among the goals of the INSPECT Program. New programs are being piloted across the state for electronic health and medical record integration. Responsible physicians are registering each day to protect both themselves and their patients by being armed with information from this database. Learn more by using the Practitioner User Guide.

See training events for INSPECT Prescription Drug Monitoring Program's use and understanding.